Leadcare Plus News Today

BOSTON — A Massachusetts company will pay $42 million to settle claims that it concealed a medical device malfunction that produced inaccurately low lead test results for tens of thousands

BOSTON — A Massachusetts company will pay $42 million to settle claims that it concealed a medical device malfunction that produced inaccurately low lead test results for tens of thousands

Magellan Diagnostics admits that it misled customers and the FDA about a device malfunction that produced inaccurately low results in lead level blood tests for potentially tens of thousands of children and other patients.

A Massachusetts-based company will plead guilty to resolve allegations that it knowingly concealed a flaw in its lead blood tests that caused numerous inaccurate results.

Magellan Diagnostics, Inc. pleaded guilty to criminal charges for concealing a device malfunction. They now owe more than $42 million in fines.

BOSTON — A Massachusetts company will pay $42 million to settle claims that it concealed a medical device malfunction that produced inaccurately low lead test results for tens of thousands

BOSTON — State public health officials say they will continue using lead testing systems that have been linked to two recalls and a federal indictment against former executives who allegedly

Three former executives of a company that makes machines that test lead levels in humans deliberately concealed a problem with the devices that produced

BOSTON — Three former executives of a Billerica-based medical device company are facing federal charges for allegedly concealing flaws in a lead-testing system that authorities say produced inaccurate results for

The problems at Magellan Diagnostics in North Billerica first became public in 2017 when the Food and Drug Administration warned Americans that the company was actually having serious issues with some of its devices returning false results.